Steroid Hormone Receptors

Palazestrant View larger

Palazestrant

AT72945

CAS 2092925-89-6

More details

Molarity Calculation Cart®

HOW TO ORDER

$249.00

$249.00 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $112.05 Total: $11,205.00
150 $129.48 Total: $6,474.00
125 $151.89 Total: $3,797.25
110 $179.28 Total: $1,792.80
15 $211.65 Total: $1,058.25

Data sheet

Molecular FormulaC28H36FN3O
Molecular Weight449.6
CAS Numbers2092925-89-6
Storage Condition0C Short Term, -20C Long Term
SolubilityDMSO
Purity98% by HPLC
SMILES CodeC(C(C)(C)F)N1[C@@H](C2=C(C=3C(N2)=CC=CC3)C[C@H]1C)C4=CC=C(OC5CN(CCC)C5)C=C4
ReferencesParisian AD, et al. Palazestrant [OP-1250], A Complete Estrogen Receptor Antagonist, Inhibits Wild-type and Mutant ER-positive Breast Cancer Models as Monotherapy and in Combination. Mol Cancer Ther. 2024 Mar 4;23[3] 285-300.

More info

Palazestrant (OP-1250) is an orally available and highly potent estrogen receptor antagonist and selective ER degrader with antitumor activity.Palazestrant inhibits 17b-estradiol (E2), inhibits MCF7 and CAMA-1 cell proliferation, and can be used in breast cancer research.